Only around a fifth of women at higher risk of developing breast cancer think they need to take a drug proven to help prevent the disease.
Rachel, from East Sussex, shares how her sister Thekla’s breast cancer diagnosis has affected the family so far.
Combining a targeted drug with hormone therapy could extend survival for some women with advanced breast cancer, according to new trial results.
An immunotherapy drug has shown promise for the first time in a form of aggressive breast cancer.
New computer simulation study suggests only screening women deemed at a ‘high risk’ of breast cancer could help to reduce unnecessary diagnoses.
Older breast cancer patients in England less likely to survive than in four other European countries
Older women diagnosed with breast cancer in England are less likely to survive their disease than those in Belgium, Poland, Ireland and the Netherlands.
A test that measures gene activity can help tailor treatment for some women with early stage breast cancer, sparing them chemotherapy.
Six months of breast cancer treatment ‘could be as effective as 12’ in some women with early stage disease
Six months of treatment could be as effective as 12 months for women with a type of early stage breast cancer, according to unpublished clinical trial results.
In the immediate aftermath, estimating the numbers affected by a breast screening error might do more harm than good.
Around 450,000 women in England missed out on a routine breast screening appointment due to an NHS failure to send invitations.